Jade Biosciences, Inc.
JBIO
$7.45
$0.050.68%
NASDAQ
| 03/31/2025 | |||||
|---|---|---|---|---|---|
| Revenue | -- | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -- | ||||
| Cost of Revenue | -- | ||||
| Gross Profit | -- | ||||
| SG&A Expenses | 3.36M | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 23.38M | ||||
| Operating Income | -23.38M | ||||
| Income Before Tax | -38.17M | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -38.17M | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -38.17M | ||||
| EBIT | -23.38M | ||||
| EBITDA | -- | ||||
| EPS Basic | -12.10 | ||||
| Normalized Basic EPS | -4.51 | ||||
| EPS Diluted | -12.10 | ||||
| Normalized Diluted EPS | -4.51 | ||||
| Average Basic Shares Outstanding | 3.16M | ||||
| Average Diluted Shares Outstanding | 3.16M | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||